National Repository of Dissertations in Serbia
    • English
    • Српски
    • Српски (Serbia)
  • English 
    • English
    • Serbian (Cyrilic)
    • Serbian (Latin)
  • Login
View Item 
  •   NaRDuS home
  • Универзитет у Новом Саду
  • Факултет техничких наука
  • View Item
  •   NaRDuS home
  • Универзитет у Новом Саду
  • Факултет техничких наука
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Upravljanje faktorima rizika u distributivnim kanalima farmaceutskih kompanija

Risk assessment in the distribution channels of pharmaceutical companies

Thumbnail
2021
Disertacija_11502.pdf (3.598Mb)
Izvestaj_komisije_11502.pdf (155.2Kb)
Author
Grujić, Jelena
Mentor
Milisavljević, Stevan
Committee members
Ćosić, Ilija
Maksimović, Rado
Brkljač, Nebojša
Đapan, Marko
Milisavljević, Stevan
Metadata
Show full item record
Abstract
Predmet istraživanja ovog rada je proučavanje farmaceutskih kompanija i rizičnih faktora koji se pojavljuju prilikom distribucije lekova. Suština istraživanja je sagledavanje potencijalnih faktora rizika u poslovnim procesima farmaceutskih kompanija, kao i u njihovim distributivnim kanalima. Ovo istraživanje obuhvata stručnjake iz deset farmaceutskih kompanija koje posluju na teritoriji jugoistočne Evrope. Istraživanje rizika u farmaceutskim kompanijama ima za cilj održavanje otpornosti, ostvarivanje kvaliteta i kontinuiteta upravljanja distribucije lekova, efektivno i efikasno upravljanje promenama u okruženju farmaceutskih kompanija i održavanje fleksibilnosti prilikom uvođenja lekova na tržište. U radu će biti prikazane smernice za upravljanje faktorima rizika u distributivnim kanalima farmaceutskih kompanija.
The subject of this paper is the study of pharmaceutical companies and the risk factors that occur during distribution of drugs. The essence of the study is to assess the potential risk factors in the business processes of pharmaceutical companies, as well as in their distribution channels. This research includes experts from ten pharmaceutical companies that operate in Southeast Europe. The study of risk in the pharmaceutical companies aims to maintain the resistance, providing high quality and continuity of management of distribution of drugs, effective and efficient management of changes in the environment of pharmaceutical companies and the maintenance of flexibility when introducing drugs to the market. The paper will present the guidelines for the management of risk factors in the distribution channels of pharmaceutical companies.
Faculty:
Универзитет у Новом Саду, Факултет техничких наука
Date:
27-09-2021
Keywords:
Faktori rizika, distributivni kanali, farmaceutske kompanije / Risk factor, distribution channels, pharmaceutical companies
[ Google Scholar ]
Handle
https://hdl.handle.net/21.15107/rcub_nardus_18569
URI
https://www.cris.uns.ac.rs/DownloadFileServlet/Disertacija162585529442261.pdf?controlNumber=(BISIS)117948&fileName=162585529442261.pdf&id=18017&source=NaRDuS&language=sr
https://www.cris.uns.ac.rs/record.jsf?recordId=117948&source=NaRDuS&language=sr
https://www.cris.uns.ac.rs/DownloadFileServlet/IzvestajKomisije162585631766146.pdf?controlNumber=(BISIS)117948&fileName=162585631766146.pdf&id=18020&source=NaRDuS&language=sr
https://nardus.mpn.gov.rs/handle/123456789/18569

DSpace software copyright © 2002-2015  DuraSpace
About NaRDus | Contact us

OpenAIRERCUBRODOSTEMPUS
 

 

Browse

All of DSpaceUniversities & FacultiesAuthorsMentorCommittee membersSubjectsThis CollectionAuthorsMentorCommittee membersSubjects

DSpace software copyright © 2002-2015  DuraSpace
About NaRDus | Contact us

OpenAIRERCUBRODOSTEMPUS